4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shandong Weigao Group Medical Polymer Company Limited (1066) operates in the Medical Instruments & Supplies industry and is headquartered in Weihai, China with about 13,307 employees. Its market capitalization is roughly CNY 15 billion. In the fiscal year ended 2025-12-31, 1066 reported CNY 13.4B in revenue and CNY 1.6B in net income.
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 13.4B | CNY 13.1B | CNY 13.2B | CNY 13.7B | — |
| Gross Profit | CNY 6.4B | CNY 6.6B | CNY 6.6B | CNY 7.3B | — |
| Operating Income (EBIT) | CNY 1.9B | CNY 2.4B | CNY 2.3B | CNY 3.1B | — |
| Net Income | CNY 1.6B | CNY 2.1B | CNY 2.0B | CNY 2.8B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 1.0B) | (CNY 871M) | (CNY 733M) | (CNY 742M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 36.0B | CNY 34.8B | CNY 33.7B | CNY 33.4B | — |
| Total Liabilities | CNY 10.2B | CNY 9.4B | CNY 9.7B | CNY 9.8B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1066 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms